Paper36948592
Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
Cronin JM and 1 other. Drug Metab Dispos, 2023. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research. Papers, record 36948592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948592
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Recombinant | Major topic |
| MicroRNAs | Major topic |
| RNA, Small Interfering | |
| Metabolic Clearance Rate | |
| Technology | |
| Recombinant Proteins | |
| Pharmacokinetics |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA093373 | NCI NIH HHS | United States | P30CA093373 | PubMed | NIH RePORTER |
| T32 GM144303 | NIGMS NIH HHS | United States | T32GM144303 | PubMed and NIH | NIH RePORTER |
| R01 CA225958 | NCI NIH HHS | United States | R01CA225958 | PubMed and NIH | NIH RePORTER |
| R35 GM140835 | NIGMS NIH HHS | United States | R35GM140835 | PubMed and NIH | NIH RePORTER |
| R01 CA253230 | NCI NIH HHS | United States | R01CA253230 | PubMed and NIH | NIH RePORTER |
References165
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,900,685 | Double promoter expression systems for recombinant protein production by industrial microorganisms. | Appl Microbiol Biotechnol | 2017 | https://conductscience.org/library/papers/28900685 | PubMed |
| 2 | 27,723,879 | Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results. | JAMA Intern Med | 2016 | https://conductscience.org/library/papers/27723879 | PubMed |
| 3 | 10,678,174 | Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. | Mol Cell | 2000 | https://conductscience.org/library/papers/10678174 | PubMed |
| 4 | 9,788,996 | Directed evolution of a thermostable esterase. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9788996 | PubMed |
| 5 | 25,161,167 | Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells. | Drug Metab Dispos | 2014 | https://conductscience.org/library/papers/25161167 | PubMed |
| 6 | 3,310,532 | P-450 cytochromes: structure and function. | Adv Enzymol Relat Areas Mol Biol | 1987 | https://conductscience.org/library/papers/3310532 | PubMed |
| 7 | 4,042,523 | Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. | Clin Pharmacol Ther | 1985 | https://conductscience.org/library/papers/4042523 | PubMed |
| 8 | 34,086,286 | Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34086286 | PubMed |
| 9 | 7,487,078 | A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. | Arch Biochem Biophys | 1995 | https://conductscience.org/library/papers/7487078 | PubMed |
| 10 | 14,676,196 | Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14676196 | PubMed |
| 11 | 1,123,353 | Purified liver microsomal cytochrome P-450. Separation and characterization of multiple forms. | J Biol Chem | 1975 | https://conductscience.org/library/papers/1123353 | PubMed |
| 12 | 21,219,875 | Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. | Biochem Pharmacol | 2011 | https://conductscience.org/library/papers/21219875 | PubMed |
| 13 | 12,424,899 | Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5. | Methods Enzymol | 2002 | https://conductscience.org/library/papers/12424899 | PubMed |
| 14 | 29,061,583 | Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells. | Drug Metab Dispos | 2018 | https://conductscience.org/library/papers/29061583 | PubMed |
| 15 | 18,295,882 | Construction and use of new cloning vectors for the rapid isolation of recombinant proteins from Escherichia coli. | Plasmid | 2008 | https://conductscience.org/library/papers/18295882 | PubMed |
| 16 | 10,508,682 | A high-throughput digital imaging screen for the discovery and directed evolution of oxygenases. | Chem Biol | 1999 | https://conductscience.org/library/papers/10508682 | PubMed |
| 17 | 28,244,990 | The chemical evolution of oligonucleotide therapies of clinical utility. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/28244990 | PubMed |
| 18 | 17,125,407 | Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. | Expert Opin Drug Metab Toxicol | 2006 | https://conductscience.org/library/papers/17125407 | PubMed |
| 19 | 22,266,943 | Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001. | Nature | 2012 | https://conductscience.org/library/papers/22266943 | PubMed |
| 20 | 29,792,703 | Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2. | J Med Chem | 2018 | https://conductscience.org/library/papers/29792703 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,395,640 | Bioengineered miR-148a-3p suppresses glycolysis and amino acid homeostasis in hepatocellular carcinoma cells by regulating multiple solute carrier transporters. | Liver Res | 2026 | https://conductscience.org/library/papers/42395640 | PubMed |
| 41,905,330 | Comparative effectiveness of 7 major human let-7-5p isoforms to modulate target gene expression in liver cells. | Drug Metab Dispos | 2026 | https://conductscience.org/library/papers/41905330 | PubMed |
| 41,601,978 | Characterization of the biodistribution profile of a human Dialyzable Leukocyte Extract (hDLE) by in vivo fluorescence imaging: a strategy to infer the ADME profile of complex multipeptide drugs. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41601978 | PubMed |
| 40,772,015 | A Comprehensive Review of Theaflavins: Physiological Activities, Synthesis Techniques, and Future Challenges. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40772015 | PubMed |
| 39,585,047 | Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures. | Noncoding RNA | 2024 | https://conductscience.org/library/papers/39585047 | PubMed |
| 39,114,355 | Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39114355 | PubMed |
| 38,472,371 | Essential factors, advanced strategies, challenges, and approaches involved for efficient expression of recombinant proteins in Escherichia coli. | Arch Microbiol | 2024 | https://conductscience.org/library/papers/38472371 | PubMed |
| 37,930,837 | INTEDE 2.0: the metabolic roadmap of drugs. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/37930837 | PubMed |
| 37,819,041 | VARIDT 3.0: the phenotypic and regulatory variability of drug transporter. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/37819041 | PubMed |
| 37,696,583 | Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin. | Pharmacol Rev | 2023 | https://conductscience.org/library/papers/37696583 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36948592
GET https://conductscience.org/api/papers/v1/36948592/references?page=2